| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $48.6M | — | +48.9% |
| Cost of Revenue | $27.7M | — | +44.9% |
| Gross Profit | $20.8M | — | +54.6% |
| R&D Expense | $16.1M | — | +7.3% |
| SG&A Expense | $16.1M | — | +1.4% |
| Operating Income | -$19.2M | — | +19.4% |
| Pre-tax Income | -$16.9M | — | +22.5% |
| Income Tax | $552K | — | +183.1% |
| Net Income | -$17.5M | — | +20.7% |
| EPS (Basic) | -$0.28 | — | +33.3% |
| EPS (Diluted) | -$0.28 | — | +33.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $78.7M | +16.8% | +45.8% |
| Short-term Investments | $94.4M | -33.1% | -17.3% |
| Accounts Receivable | $26.2M | -5.6% | +46.3% |
| Inventory | $29.9M | +26.8% | +97.8% |
| Current Assets | $251.0M | -10.0% | +14.8% |
| Total Assets | $381.5M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$7.3M | — | -49.2% |
| Capital Expenditures | $2.6M | — | +363.9% |
| Investing Cash Flow | $17.1M | — | +35.5% |
| Financing Cash Flow | $705K | — | +6.8% |
| Free Cash Flow | -$9.8M | — | -81.2% |
| +42.0% |
| Current Liabilities | $84.3M | +18.7% | -0.8% |
| Total Liabilities | $105.9M | +20.6% | +5.2% |
| Stockholders' Equity | $275.6M | +5.3% | +64.1% |